FIELD: medicine, obstetrics.
SUBSTANCE: it is necessary to perform medicinal therapy. Additionally, one should affect with waves of millimeter range, wave length being 7.1 mm to affect biologically active points F2 and E 36 due to autonomous applicator-emitter with heparin. Course lasts for24 h and consists of 10 procedures. The method normalizes hemostasiological parameters and rheological blood properties.
EFFECT: higher efficiency of therapy.
1 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPLEX METHOD FOR TREATING THE CASES OF CHRONIC FETOPLACENTARY INSUFFICIENCY | 2001 |
|
RU2198701C2 |
METHOD OF TREATMENT OF CHRONIC FETOPLACENTAL INCOMPETENCE | 1997 |
|
RU2123363C1 |
METHOD FOR PREVENTING GESTOSIS IN THE CASES OF HIGH RISK OF ITS DEVELOPMENT | 2004 |
|
RU2262960C1 |
METHOD FOR PROPHYLAXIS OF PREGNANCY GESTOSIS | 2005 |
|
RU2281774C1 |
METHOD OF TREATING FETOPLACENTAL INSUFFICIENCY | 2011 |
|
RU2465929C1 |
METHOD FOR TREATING FETOPLACENTAL DEFICIENCY | 2002 |
|
RU2215563C1 |
METHOD FOR PREVENTION OF FETOPLACENTAL INSUFFICIENCY IN GESTATIONAL AUTOHEMODILUTION | 2008 |
|
RU2375087C1 |
METHOD FOR TREATMENT OF CHRONIC PLACENTAL INSUFFICIENCY | 2002 |
|
RU2228749C1 |
METHOD FOR DRUG-FREE PREVENTION OF PREGNANCY COMPLICATIONS | 2013 |
|
RU2541745C2 |
METHOD OF DELIVERY PREPARATION OF PREGNANT WOMEN AT HIGH RISK OF INITIAL UTERINE INERTIA | 2006 |
|
RU2324510C2 |
Authors
Dates
2004-11-20—Published
2003-04-30—Filed